Combined use of ecteinascidin-743 and platinum...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/495 (2006.01) A61K 31/282 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2525887

ET-743 can be used to mitigate resistance to and potentiate the cytotoxic effects of a platinum coordination complex anti-neoplastic agent in a human cancer patient.

L'ectéinascidine-743 peut être utilisée afin d'atténuer la résistance à des effets cytotoxiques d'un agent antinéoplasique complexe de coordination platine et afin d'augmenter ces effets cytotoxiques chez un patient humain souffrant du cancer.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Combined use of ecteinascidin-743 and platinum... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combined use of ecteinascidin-743 and platinum..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combined use of ecteinascidin-743 and platinum... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1746827

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.